Zynerba Pharmaceuticals (ZYNE)

[Leonard McKinley]

I can no longer hold my tongue. This company is a table pounding, screaming buy. That is my opinion. The results reported show that the delivery system works (better than GWPH) with totally safe results. The approval of the product is basically a layup from here. GWPH has a market cap of $4.5 billion and it has more serious side effects that are gastro-intestinal because their product is ingested. It is highly likely that once approved, Zyne's product will actually take share from GWPH. In addition, Zyne's targeted indications are all supported with strong historical and anecdotal information which virtually guarantees effectiveness and safety is already proven. In the end, it is Zyne that will be worth billions, and billions more than GWPH, and GWPH may well turn into a short sale in a couple of years.
The current price action is pure hysteria motivated by ignorance, fear, margin calls and stop losses.
BUY, BUY, BUY!